Patents
Patents for C12N 1 - Micro-organisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving micro-organisms or compositions thereof; Processes of preparing or isolating a composition containing a micro-organism; Culture media therefor (148,866)
05/2002
05/23/2002WO2002040681A1 The polypeptide fragments of hepatitis e virus, the vaccine composition comprising said fragments and the diagnostic kits
05/23/2002WO2002040679A2 Corynebacterium glutamicum promoters
05/23/2002WO2002040676A2 Mutant allergens
05/23/2002WO2002040671A2 Immunoglobulin superfamily proteins
05/23/2002WO2002040670A2 A human g-protein coupled receptor, hgprbmy8, expressed hig hly in brain
05/23/2002WO2002040669A1 Novel guanosine triphosphate (gtp) binding protein-coupled receptor protein, bg37
05/23/2002WO2002040666A2 Fat regulated genes, uses thereof, and compounds for modulating same
05/23/2002WO2002040660A2 Promoter for the functional characterisation of g-protein coupled receptors in the yeast saccharomyces cerevisiae
05/23/2002WO2002040659A1 POLYPEPTIDES HAVING α-ISOMALTOSYL TRANSFERASE ACTIVITY
05/23/2002WO2002040652A2 Novel soluble endoproteases for the in vitro processing of recombinant proteins
05/23/2002WO2002040650A2 Methods for large scale production of recombinant dna-derived tpa or k2s molecules
05/23/2002WO2002040649A1 Slo2 and slo4, novel potassium channel proteins from human brain
05/23/2002WO2002040643A1 Microorganisms producing l-glutamine and processes for producing l-glutamine using the same
05/23/2002WO2002040642A1 Bacterial control by bacteriophages
05/23/2002WO2002040641A2 Binary bac vector and uses thereof
05/23/2002WO2002040638A2 Mycologic genera specific selective agar and method of manufacture
05/23/2002WO2002040545A2 Reduction of the nonspecific animal toxicity of immunotoxins by mutating the framework regions of the fv to lower the isoelectric point
05/23/2002WO2002040541A2 Transporters and ion channels
05/23/2002WO2002040538A2 Regulation of human nmda receptor
05/23/2002WO2002040535A2 Compositions and methods relating to ovary specific genes and proteins
05/23/2002WO2002040515A2 Exoenzyme toxin of aeromonas salmonicida, and uses thereof
05/23/2002WO2002040514A2 Type iii secretion pathway in aeromonas salmonicida, and uses therefor
05/23/2002WO2002040501A2 Membrane scaffold proteins
05/23/2002WO2002040413A1 Nutrient delivery system
05/23/2002WO2002040046A1 Salmonella vaccine
05/23/2002WO2002039885A2 Compositions and methods for the therapy and diagnosis of ovarian cancer
05/23/2002WO2002039834A1 Nutritional composition for an immune condition
05/23/2002WO2002004609A3 Mutations of cryptic splice sites in cre and cre fused proteins for improvement of expression and inducibility
05/23/2002WO2002003911B1 Prevention and treatment of alzheimer's disease
05/23/2002WO2002002779A3 Nucleotide sequences which encode the plsc protein
05/23/2002WO2001095716A3 High temperature cryogenic preservation of biologically active material
05/23/2002WO2001088117A3 In vitro fucosylation recombinant glycopeptides
05/23/2002WO2001087884A3 Polyketide derivatives
05/23/2002WO2001085792A8 Mu-1, member of the cytokine receptor family
05/23/2002WO2001083774A3 Novel mutated form of arginine deiminase
05/23/2002WO2001081603A3 Trophic conversion of obligate phototrophic algae through metabolic engineering
05/23/2002WO2001081577A3 Dna encoding the prost 03 polypeptide
05/23/2002WO2001079444A3 Albumin fusion proteins
05/23/2002WO2001073028A3 A p-selectin glycoprotein ligand (psgl-1) binding protein and uses therefor
05/23/2002WO2001064837A8 β NETRIN AND USES THEREOF
05/23/2002WO2001047946A9 GFRα1-RET SPECIFIC AGONISTS AND METHODS THEREFOR
05/23/2002WO2001040271A9 Cancer associated antigens and uses therefor
05/23/2002WO2001029261A3 A method for high-density microarray mediated gene expression profiling
05/23/2002WO2001029197A3 Novel germinal center kinase cell cycle proteins, compositions and methods of use
05/23/2002US20020061848 An specific polypeptides comprising a Chlamydia antigen and the use of such polypeptides for the serodiagnosis and treatement of Chlamydia infection
05/23/2002US20020061834 Human G-protein Chemokine receptor (CCR5) HDGNR10
05/23/2002US20020061582 Method of stimulating the mating of microorganisms in liquid medium
05/23/2002US20020061581 Nuclelotide sequences coding immunoglobulin segment; for use in diagnosis and prevention of viral infection and disease
05/23/2002US20020061580 Microorganism for use in the generation of preferential enzyme; for use in genertaion of animal feeds; for use in cleaning textiles
05/23/2002US20020061579 Counter selection strategy for Gram-negative bacteria
05/23/2002US20020061578 Nucleotide sequences coding enzymatic polypeptide for use as tool in genetic engineering
05/23/2002US20020061576 Tissue plasminogen activator-like protease
05/23/2002US20020061569 Nuclelotide sequences for use in the prevention of proliferation of microorganisms
05/23/2002US20020061559 Preferential protein for use in the diagnosis and treatment of cancers; antitumor agents; anticarcinogeneic agents
05/23/2002US20020061555 Generating microorganismal gene expression inhibitors; obtain microorganism, culture, express modulators of gene activity in culture, recover gene expression inhibitors
05/23/2002US20020061547 Microorganism for use in the generation of colored particle; for use in foods, cosmetics and medicine
05/23/2002US20020061545 Streptococcus pneumoniae antigens and vaccines
05/23/2002US20020061528 Expression vector; for use in the controlled expression genes
05/23/2002US20020061527 Human DNA topoisomerase I alpha
05/23/2002US20020061513 Isolation of preferential cellular components; obtain genetically engineered cells, express vector, detect polypeptides on support, recover polypeptides
05/23/2002US20020061307 Polyalkylene oxide-modified single chain polypeptides
05/23/2002US20020061306 DNA sequences encoding proteins having ability to bind alpha 2-macroglobulin; expression vectors; immunology
05/23/2002US20020061292 Dietary or pharmaceutical composition for use for the prevention or treatment of hyperoxaluria
05/23/2002DE10057801A1 New polynucleotide encoding the CysQ transporter of coryneform bacteria, useful, when over expressed, for increasing fermentative production of amino acids
05/23/2002DE10057755A1 New nucleic acid encoding plant phosphomevalonate kinase, useful for identifying modulators, potentially useful as herbicides and growth regulators
05/23/2002DE10055512A1 L-Aminosäure-Oxidase aus Rhodococcus-Arten L-amino acid oxidase from Rhodococcus species
05/23/2002CA2749307A1 Promoter sequence of a gene encoding an exoenzyme toxin of aeromonas salmonicida, and uses therefor
05/23/2002CA2707684A1 Novel exoenzyme toxin of aeromonas salmonicida, and uses therefor
05/23/2002CA2467360A1 Exoenzyme toxin of aeromonas salmonicida, and uses therefor
05/23/2002CA2467309A1 Type iii secretion pathway in aeromonas salmonicida, and uses therefor
05/23/2002CA2429458A1 Process for producing coenzyme q10
05/23/2002CA2429455A1 Fat regulated genes, uses thereof, and compounds for modulating same
05/23/2002CA2429214A1 Guanosine triphosphate (gtp)-binding protein-coupled receptor protein, bg37
05/23/2002CA2429195A1 Immunoglobulin superfamily proteins
05/23/2002CA2429142A1 Maize yellow stripe1 and related genes
05/23/2002CA2428850A1 Isolated human kinase proteins, nucleic acid molecules encoding human kinase proteins, and uses thereof
05/23/2002CA2428350A1 Slo2 and slo4, novel potassium channel proteins from human brain
05/23/2002CA2427902A1 Compositions and methods for the therapy and diagnosis of ovarian cancer
05/23/2002CA2427010A1 Transporters and ion channels
05/23/2002CA2426100A1 Metabolic rate shifts in fermentations expressing recombinant proteins
05/23/2002CA2425692A1 Preventing corrosion with beneficial biofilms
05/22/2002EP1207204A1 Tissue-specific promoters from sugar beet
05/22/2002EP1207203A2 DNA sequence and papillomavirus vaccine
05/22/2002EP1207198A1 Novel g protein-coupled receptor protein and dna thereof
05/22/2002EP1206573A1 26 human secreted proteins
05/22/2002EP1206570A1 Screening for udp-glucose:glycoprotein glucosyltransferase (uggt) activity
05/22/2002EP1206560A2 Plant gene expression, controlled by constitutive plant v-atpase promoters
05/22/2002EP1206556A2 Method of isolating secretion signals in lactic acid bacteria, and secretion signals isolated from lactococcus lactis
05/22/2002EP1206555A1 F v? antibody construct comprising binding sites for a cd16 receptor and a cd30 surface protein
05/22/2002EP1206553A2 Isomerase proteins
05/22/2002EP1206551A2 Enzymatic synthesis of deoxyribonucleosides
05/22/2002EP1206549A1 Basb119 polypeptide and polynucleotide from moraxella catarrhalis
05/22/2002EP1206548A1 Basb118 polypeptide and polynucleotide from moraxella catarrhalis
05/22/2002EP1206543A2 Membrane associated proteins
05/22/2002EP1206541A1 Dendritic enriched secreted lymphocyte activation molecule
05/22/2002EP1206540A2 Dna sequences isolated from human colonic epithelial cells
05/22/2002EP1206537A2 Nucleic acids and polypeptides of invertebrate twik channels and methods of use
05/22/2002EP1206529A2 UDP-N-ACETYLGLUCOSAMINE: GALACTOSE-BETA 1,3-N-ACETYLGALACTOSAMINE-ALPHA-R/(GlcNAc to GalNAc) BETA 1,6-N-ACETYLGLUCOSAMINYLTRANSFERASE, C2GnT3
05/22/2002EP1206523A1 Bifidobacteria preventing diarrhea caused by pathogenic bacteria
05/22/2002EP1206491A1 Tgf-beta receptor polynucleotides, polypeptides, and antibodies